CME

CME


Latest Episodes

Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
July 15, 2022

Host: Mark Socinski, MD Guest: Jennifer Marie Suga, MD, MPH There are new targeted therapies that are now approved for the treatment of advanced non-small cell lung cancer. Dr. Mark Socinski & Dr. Marie Suga discuss evolving diagnostic approach

HER2-Directed ADCs in Breast Cancer
June 30, 2022

HER2-Directed ADCs in Breast Cancer

TROP2-Directed ADCs in Breast Cancer
June 30, 2022

HER2-Directed ADCs in Breast Cancer

HER3-Directed ADCs in Breast Cancer
June 30, 2022

HER2-Directed ADCs in Breast Cancer

HER2-Directed ADCs in Lung Cancer
June 30, 2022

HER2-Directed ADCs in Breast Cancer

TROP2-Directed ADCs in Lung Cancer
June 30, 2022

HER2-Directed ADCs in Breast Cancer

HER3-Directed ADCs in Lung Cancer
June 30, 2022

HER2-Directed ADCs in Breast Cancer

HER2-Directed ADCs in Gastric Cancer
June 30, 2022

HER2-Directed ADCs in Breast Cancer

Nectin-4-Directed ADCs in Bladder Cancer
June 30, 2022

HER2-Directed ADCs in Breast Cancer

TROP2-Directed ADCs in Bladder Cancer
June 30, 2022

HER2-Directed ADCs in Breast Cancer